Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Ou connectez-vous avec votre réseau social favori

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Malcisbo AG

Malcisbo AG_logo
4
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Sweet Vaccines

Schlieren, ZH, Switzerland

Send a message

Anglais

Malcisbo AG

Anglais

Malcisbo is a biotech company developing anti-bacterial vaccines. We are specialized in glycoengineering technologies resulting in efficient glycoconjugate vaccines. Our focus is on bacterial diseases targeting animal health, human food safety and zoonotic diseases. Our first vaccine aims at the medical areas of human Campylobacter infections (prevention of human food poisoning due to chicken meat contaminated with Campylobacter). Reduction of Campylobacter in chickens will reduce the...

See more

Malcisbo is a biotech company developing anti-bacterial vaccines. We are specialized in glycoengineering technologies resulting in efficient glycoconjugate vaccines. Our focus is on bacterial diseases targeting animal health, human food safety and zoonotic diseases. Our first vaccine aims at the medical areas of human Campylobacter infections (prevention of human food poisoning due to chicken meat contaminated with Campylobacter). Reduction of Campylobacter in chickens will reduce the infection rate of humans which currently is at 9 Mio cases per year in the EU causing an estimated €2.3bn damage.

 A second target is pig meat production. Infections with Actinobacillus pleuropneumoniae cause major economic loss in swine industry due to mortality, retarded growth rate and antibiotic medication. Other indications are envisaged.

Malcisbo's technology allows cost-efficient production of vaccines in line with the goals of authorities to reduce the use of antibiotics.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Team member(s)

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1012 Entities

Communities

Our history

Start in 2010

  • 2010

    foundation of company by Markus Aebi, Lino Camponovo, Irene Schiller and Bruno Oesch

  • 2011

    Winner of Swiss Technogy Award

  • 2011

    W.A. de Vigier Enterpreneurship Prize

  • 2012

    CTI startup label

to be continued ...